DAWN- Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc. (DAWN) has 13 insiders with recent SEC Form 4 filings, including 1 buy and 14 sells. DAWN is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 237.0K | $5.10M | - | |
| CFO | 126.0K | $2.71M | - | |
| Other | 114.0K | $2.45M | - | |
| Other | 74.0K | $1.59M | - | |
| Other | 70.0K | $1.51M | - |
Activity
Buys and sells only
Transactions
10 filings · page 12
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 18, 2022 | Bender Jeremy76 | Chief Executive Officer | Sell | 2,600 | $20.00 | $52,003.12 | -0.2% | +8.5% | -36.3% | |
| Jul 18, 2022 | Grant Papanek Julie78 | Director | Sell | 2,600 | $20.00 | $52,001.04 | -0.6% | +8.5% | -36.3% | |
| Jul 8, 2022 | York Charles N II76 | COO, CFO And Secretary | Sell | 1,416 | $20.00 | $28,320.00 | -0.4% | +4.6% | -40.9% | |
| Jul 8, 2022 | Bender Jeremy76 | Chief Executive Officer | Sell | 1,795 | $20.00 | $35,900.00 | -0.1% | +4.6% | -40.9% | |
| Jul 8, 2022 | Grant Papanek Julie78 | Director | Sell | 1,242 | $20.00 | $24,840.00 | -0.3% | +4.6% | -40.9% | |
| Jul 5, 2022 | York Charles N II76 | COO, CFO And Secretary | Sell | 2,279 | $20.00 | $45,580.00 | -0.3% | +3.9% | -39.0% | |
| Jul 5, 2022 | Bender Jeremy76 | Chief Executive Officer | Sell | 2,603 | $20.00 | $52,060.00 | -0.1% | +3.9% | -39.0% | |
| Jul 5, 2022 | Grant Papanek Julie78 | Director | Sell | 1,800 | $20.00 | $36,000.00 | -0.2% | +3.9% | -39.0% | |
| Jul 1, 2022 | Blackman Samuel C.77 | Chief Medical Officer | Sell | 10,000 | $18.72 | $187,158.09 | -0.3% | -1.7% | -40.2% | |
| Jun 17, 2022 | Atlas Venture Opportunity Fund Ii, L.P. | 10% Owner | Buy | 766,667 | $15.00 | $11,500,005.00 | New | +44.3% | -16.1% |